Search Results 321-330 of 11970 for Lupus

  1. Interferon alfa-2b (injection route) - Mayo Clinic

    Autoimmune disorders (eg, psoriasis, Raynaud disease, rhabdomyolysis, rheumatoid arthritis, sarcoidosis, systemic lupus erythematosus, or vasculitis) or ...

  2. Neutropenia (low neutrophil count) Causes - Mayo Clinic

    Lupus · Rheumatoid arthritis. Bone marrow disorders. Aplastic anemia · Myelodysplastic syndromes · Myelofibrosis. Other causes. Genetic conditions such as ...

  3. Lansoprazole, amoxicillin, and clarithromycin (oral route) - Mayo Clinic

    Cutaneous or systemic lupus erythematosus may occur or get worse in patients receiving a PPI. Call your doctor right away if you have joint pain or a skin rash ...

  4. Publications - Matthew L. Basiaga, D.O. - Mayo Clinic

    Lupus Sci Med. 2022 Nov; 9 (1) View PubMed; Michniacki TF, Walkovich K ... Lupus. 2015 Oct; 24 (12):1335-7 Epub 2015 May 13. View PubMed; Cheung JM ...

  5. Sutimlimab-jome (intravenous route) - Mayo Clinic

    Systemic lupus erythematosus (SLE)—Use with caution. May make these conditions worse. Back to top. Proper Use. A nurse or other trained health professional ...

  6. Heart murmurs - Symptoms & causes - Mayo Clinic

    Certain autoimmune disorders such as lupus and rheumatoid arthritis; Heart valve disease; High blood pressure in the lungs (pulmonary hypertension); History of ...

  7. Diffuse large B-cell lymphoma - Symptoms and causes - Mayo Clinic

    Conditions may include ataxia-telangiectasia, Wiskott-Aldrich syndrome, rheumatoid arthritis and lupus. Some infections. Some infections have been linked to ...

  8. Metolazone (oral route) - Mayo Clinic

    Systemic lupus erythematosus—Use with caution. This medicine may make these conditions worse . Kidney disease or; Liver disease—Use with caution. The effects ...

  9. Joel Streed | Mayo Clinic News Network - Page 22 of 170

    Mayo Clinic will begin offering vaccine doses to all eligible patients the week[...] By Joel Streed • July 1, 2022. Lupus ...

  10. Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    * Kidney biopsy findings in addition to IgAN including those of diabetic nephropathy, membranous nephropathy, or lupus nephritis. Hypertensive vascular ...